ArticleActa oncologica (Stockholm, Sweden)2025

Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer - a population-based cohort study in Sweden.

Gunnar Wagenius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.